1. Parkinson’s Progression Markers Initiative (PPMI)

Parkinson’s Progression Markers Initiative (PPMI) About PPMI The Parkinson’s Progression Markers Initiative (PPMI) is an observational research s...

2. PPMI Dispatch: New Tool to Measure Risk of Impulse Control Disorders in Parkinson’s

The Michael J. Fox Foundation’s (MJFF) landmark study, the Parkinson’s Progression Markers Initiative (PPMI), continues around the world. Recent r...

3. PPMI Study Progress and Future Plans

The landmark Parkinson’s Progression Markers Initiative (PPMI) marches forward in its massive expansion, study leaders brought updates and ideas to ...

4. PPMI Dispatch: Closer to Predicting Disease Progression and Symptoms

The coronavirus pandemic has forced many research operations to go remote, including in our landmark Parkinson’s Progression Markers Initiative (PPM...

5. PPMI Study Update: Early Signs and Some Potential Markers

The landmark Parkinson’s Progression Markers Initiative (PPMI) study aims to better define and measure Parkinson’s disease so scientists can find ...

6. PPMI Study Shows Brain Changes Linked to Parkinson’s Progression

Two recent papers point to potential Parkinson’s biomarkers after analysis of data from The Michael J. Fox Foundation’s (MJFF) Parkinson’s Prog...

7. PPMI Study Reaches Important Milestone

The Parkinson’s Progression Markers Initiative (PPMI) has reached an important milestone: the study completed enrollment. We have now met the ambiti...

8. PPMI Shows Protein Levels Lower in Spinal Fluid of People with Parkinson’s

Principal investigator of the Parkinson’s Progression Markers Initiative (PPMI), Ken Marek, MD, presented the latest findings from the landmark bi...

9. Important PPMI Results Highlighted in USA Today

The first major study results from the Parkinson’s Progression Markers Initiative (PPMI) are highlighted in today’s edition of USA Today. The stu...

10. Marc Joins PPMI Study to Support his Wife Karen

Sunday Night Australia taped exclusive interviews with friends of the Foundation last month, including Parkinson’s Progression Markers Initiative (P...

11. Parkinson’s Progression Markers Initiative (PPMI)

12. The State of the Field: The Michael J. Fox Foundation

13. The Michael J. Fox Foundation for Parkinson’s Research Finds Parkinson’s Biomarker

In 2023, the Michael J. Fox Foundation for Parkinson’s Research (MJFF) announced an enormous leap forward in the understanding of Parkinson’s ...

14. Our MJFF Partnership

15. Researchers find potential new blood test for detecting Parkinson’s

The Michael J. Fox Foundation for Parkinson’s Research has announced that researchers at Duke University School of Medicine have found a new te...

16. Shake It Up Progress Update June 2023

In December of last year, I took on the role as CEO of Shake It Up Australia, after nearly six years as Executive General Manager. At the time, I shar...

17. Ask the MD: Sense of Smell Is a Window into Brain Health

Smell loss became a popular topic of conversation during the COVID pandemic. Many now are personally aware of the importance of sense of smell and the...

18. Alzheimer’s Drug Approval Shows Power of Protein Markers as Parkinson’s Field Seeks Same

The U.S. Food and Drug Administration (FDA) last week approved lecanemab (brand name Leqembi) developed by Eisai Co Ltd. and Biogen Inc. for people w...

19. Ask the MD: Does Parkinson’s have a signature scent

Scientists have recently discovered that the skin of people with Parkinson’s disease (PD) has a unique scent. And MJFF-funded scientists are now wo...

20. Webinar: New to Parkinson’s? Steps to take today

Navigating a Parkinson’s diagnosis can be challenging, but you’re not alone. In this audio  expert panellists share practical tips for managing t...

21. News in Context: New Drug Approved for Alzheimer’s Disease

A significant milestone in brain disease research was achieved early this week when the U.S. Food and Drug Administration (FDA) announced approval of...

22. Potential Therapy Targeting Key Parkinson’s Protein Advances in Human Trials

Another therapy in the drug development pipeline has taken a step forward with the start of a new trial in nearly 600 people with Parkinson’s. Partn...

23. Podcast: New to Parkinson’s? Steps to Take Today (Webinar)

In this audio from our  partners at The Michael J. Fox Foundation, Larry Gifford, Patient Council member at The Michael J. Fox Foundation, leads a di...

24. Key Takeaways from The Michael J. Fox Foundation’s Virtual LRRK2 Industry Summit

The Michael J. Fox Foundation (MJFF) plays a critical role in convening partners and competitors to work together on new treatments and disease measur...

25. Podcast: What’s Next for Parkinson’s: Big Trials, New Treatments and Steps toward Prevention

In the last six years, 16 new treatments have been improved for Parkinson’s but there is still much work to be done. In this audio from our Thir...

26. Do Different Genders Experience Different Types of Parkinson’s?

Research tells us that more men are diagnosed with Parkinson’s disease than women. But what do we know about how they experience symptoms and progre...

27. Ian and Karen tie the knot and raise funds for Parkinson’s

Congratulations to Ian and Karen who were married end of September and kind-heartedly asked for donations to Shake It Up instead of gifts. Their weddi...

28. Blood-Based Biomarkers in Parkinson’s

Recently, a team at Lund University published results in JAMA on a potential blood test for Alzheimer’s. It measures levels of plasma phospho-...

29. Ask the MD: Smell Loss in Coronavirus and Parkinson’s

How do we smell? Tiny odour molecules — of cookies baking in the oven, laundry that needs to be cleaned, or rosemary growing in the garden — trave...

30. Podcast – Latest in Parkinson’s Research

Earlier this month three members of The Michael J. Fox Foundation staff sat with Contributing Editor Dave Iverson to discuss the latest findings and r...

31. Podcast: 2018 Parkinson’s Research Year in Review and Look Ahead

Parkinson’s research continues to advance at a rapid pace. Led by moderator Soania Mathur, MD, co-chair of The Michael J. Fox Foundation’s Patient...

32. Study’s Measure Parkinson’s Progression

Two recent papers outline the progression of Parkinson’s disease (PD) movement or motor symptoms in distinct study populations. While these findings...

33. $24M Collaboration to improve Suuccess of Clinical Trials for People with Parkinson’s

The Michael J. Fox Foundation (MJFF), the National Institutes of Health (NIH) and five life sciences companies today announced a public-private partn...

34. Caffeine a Potential Marker for Parkinson’s

Millions of people reach for a caffeinated beverage each morning to jumpstart the day. Now, early research indicates that the stimulant that gets peop...

35. Parkinson’s Research Conference Spotlights Advances

On October 30, more than 300 leaders in Parkinson’s disease (PD) research and business development gathered in NYC for The Michael J. Fox Foundation...

36. Stem Cells Safe in Pre-Clinical Parkinson’s Disease Study

A new stem cell study, published in the journal Nature, builds on the potential for this therapy in Parkinson’s, but it’s still early days and mu...

37. New Tool may help Researcher predict Cognitive Decline In Parkinson’s

A new tool from researchers at Harvard Medical School may allow investigators to predict cognitive decline in people with Parkinson’s disease (PD), ...

38. Blood Test May Help Confirm a Parkinson’s Diagnosis

Parkinson’s disease (PD) is a complex and varied disorder with many different potential motor and non-motor symptoms. Early on, it can sometimes be ...

39. Trial Testing Drug in People with Parkinson’s and a GBA Mutation

Sanofi Genzyme has started a clinical trial for a drug targeting cellular dysfunction seen in people with Parkinson’s disease (PD) and a GBA mutat...

40. Studying the genetic link of Parkinson’s could lead to new treatments for everyone

The genetics of Parkinson’s is complex, but each new study helps us piece together a greater understanding of how key genes, such as LRRK2, contrib...

41. Common Link Across Different Causes of Parkinson’s

Parkinson’s is a variable disease — different in age of onset, experience of symptoms and cause — but a new study points to a potential common l...

42. Another Leap Forward for LRKK2 Development

Denali Therapeutics — a San Francisco biotech that launched last year focused on neurodegenerative diseases including Parkinson’s — recently an...

43. Researchers Looking to Improve Diagnosis of Parkinson’s

No objective measurement — or biomarker — currently exists to diagnose Parkinson’s disease (PD). Instead, doctors must rely on a person’s me...

44. Is Parkinson’s Disease Genetic? Maybe

Everyone in the Parkinson’s disease (PD) community likely has heard this question and asked it themselves. We say that PD is rarely caused by genet...

45. Neurologist Profile: Professor Dominic Rowe

Professor Dominic Rowe, the man at the center of some of the World’s best Parkinson’s research. Here’s what inspires him in his search for chang...

46. Study Finds Depression Linked to Increased Risk of Parkinson’s

Depression may be an early indicator of Parkinson’s disease (PD) risk, reports study findings published in the journal Neurology last week. Inves...

47. An Overview of Parkinson’s Disease Research: Questions and Answers

On Tuesday, February 19, The Michael J. Fox Foundation (MJFF) hosted the first event of the year in its Hot Topics in Parkinson’s disease (PD) Resea...

48. Shake It Up Hero – Ian Read

Ian Read is our Hero for his participation in Parkinson’s Clinical trails here in Australia. People like Ian play a HUGE role in finding the cure fo...

49. The Michael J. Fox Foundation CEO Todd Sherer Meets with Researchers Down Under

This week, Michael J. Fox Foundation CEO Todd Sherer, PhD, is attending the 17th Annual Movement Disorder Society Congress in Sydney, Australia, o...

50. A Family Affair: The Genetics of Parkinson’s

The below post is written by Genia Brin, mother of internet entrepreneur and Google Co-Founder Sergey Brin. Care of the Michael J Fox Foundation, Geni...

51. Resurrecting Tau in the Search for an Alzheimer’s (and Potentially, Parkinson’s) Cure

Over the past few months, one particular Alzheimer’s disease (AD) drug target has repeatedly been in the news for all the wrong reasons: a protein c...

52. Shake It Up Australia and The Michael J. Fox Foundation Announce First Parkinson’s Research Grant Recipient

Shake It Up Australia and The Michael J. Fox Foundation (MJFF)  today announced the first of up to $3 million worth of Australian research grants t...